Lawrence Kenyon - Sep 26, 2024 Form 4 Insider Report for Outlook Therapeutics, Inc. (OTLK)

Role
Chief Financial Officer, Director
Signature
/s/ Lawrence Kenyon
Stock symbol
OTLK
Transactions as of
Sep 26, 2024
Transactions value $
$28,446
Form type
4
Date filed
9/30/2024, 04:53 PM
Previous filing
Mar 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OTLK Common Stock Purchase $28.4K +5K +528.54% $5.69 5.95K Sep 26, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects the Issuer's 1-for-20 reverse stock split effected on March 13, 2024.